Division of Thoracic Surgery, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.
Division of Thoracic Surgery, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA; Division of Thoracic Surgery, West Roxbury VA Medical Center, 1400 VFW Pkwy, West Roxbury, MA 02132, USA.
Surg Clin North Am. 2021 Jun;101(3):443-451. doi: 10.1016/j.suc.2021.03.006.
Definitive chemoradiation therapy avoids the perioperative and long-term morbidity of esophagectomy and is the standard of care for cervical esophageal cancer. There are significant differences in tumor response to chemoradiation and recurrence patterns between squamous cell cancer and adenocarcinoma of the esophagus. Multimodality therapy for esophageal cancer continues to progress, now with the widespread use of PET scanning and possible active surveillance in patients with complete clinical response to chemoradiation. As drug development and targeted therapy trials continue to expand, our understanding of tumor biology and precision medicine will continue to refine the treatment of esophageal cancer.
根治性放化疗避免了食管切除术的围手术期和长期并发症,是治疗颈段食管癌的标准方法。食管鳞癌和腺癌对放化疗的反应和复发模式存在显著差异。食管癌的多模态治疗不断进展,现在广泛使用 PET 扫描,对于完全缓解的患者可能进行积极监测。随着药物开发和靶向治疗试验的不断扩大,我们对肿瘤生物学和精准医学的理解将继续完善食管癌的治疗。